Search Results 51-60 of 4466 for Diffuse

  1. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    ... Diffuse Large B-cell Lymphoma (R/R DLBCL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

  2. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...

  3. Cutaneous B-cell lymphoma - Symptoms and causes - Mayo Clinic

    Primary cutaneous diffuse large B-cell lymphoma, leg type usually grows fast and has a poor prognosis. This type has a high relapse rate and may spread beyond ...

  4. Brainstem tumor - Symptoms and causes - Mayo Clinic

    Diffuse midline gliomas are especially common in children, where they make up most malignant brainstem tumors. Historically, in children these tumors were ...

  5. Pediatric brain tumor research: Enhancing treatment and quality of life - Mayo Clinic

    An assessment of Mayo Clinic's new approach to radiation therapy for diffuse midline glioma. Laboratory studies of potential new therapies and drug-delivery ...

  6. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

    The purpose of this study is to determine the efficacy and safety of CTL019 in adult patients with relapsed or resistant diffuse large B-cell lymphoma.

  7. Cutaneous B-cell lymphoma - Overview - Mayo Clinic

    Primary cutaneous diffuse large B-cell lymphoma, leg type usually grows fast and has a poor prognosis. This type has a high relapse rate and may spread beyond ...

  8. A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

    A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma · Overview · Participation ...

  9. Brainstem tumor - Diagnosis and treatment - Mayo Clinic

    MRI with and without contrast can help identify common tumor types, including diffuse midline glioma (DMG) and other gliomas that can form in the brainstem. MRI ...

  10. CON-20167629-Care at MC-Offering hope to people with stomach cancer

    Travis E. Grotz, M.D., Surgical Oncologist: At Mayo Clinic, we treat all types of stomach cancer. One of the most common types of stomach cancer is the diffuse ...